BGM Group Ltd.
corporate_fare Company Profile
BGM Group Ltd. (NASDAQ:BGM) is a publicly traded company in the Life Sciences sector. Wiseek monitors BGM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- BGM Group 20-F Discloses $19.9M Loss, Material Weakness, Nasdaq Bid Price Deficiency, and a $12M Dilutive Placement
- Shareholders to Vote on Reverse Stock Split and Capital Reorganization
- BGM Group Closes $12M Private Placement at Deep Discount
- BGM Group Secures $12M in Deeply Discounted Private Placement, Potential for $27M More via Warrants
- BGM Group Announces Major Board and Co-CEO Leadership Changes
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BGM, detected from its recent SEC filings · based on capital-structure filings through 2026-05-18.
Deeply Discounted Private Placement · Significant Warrant Issuance
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BGM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.